Beam Therapeutics

BEAM

Rank 2135

Country USA

Exchange NASDAQ

Currency USD

Sector LIFE SCIENCES

Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Address 26 LANDSDOWNE STREET, CAMBRIDGE, MA, US

Beam Therapeutics - Key figures

Market cap 2.8 Billion

Revenue 60.27 Million

Profit -180,290,000

P/E Ratio No information

P/s Ratio 46.39

Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.

The company is headquartered in Cambridge, Massachusetts.